Supplemental Table S3 from Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer

2026 Open access

Read full text
Authors: Cassandra L. Moyer, Jamal L. Hill, Darian Coleman, Amanda L. Lanier, Yanxia Ma, Xiaoqian Liu, Jitesh D. Kawedia, Alejandro Contreras, Vidyasagar Vuligonda, Michelle I. Savage, Martin E. Sanders, Altaf Mohammed
+3 more Shizuko Sei, Powel H. Brown, Abhijit Mazumdar
DOI: 10.1158/1940-6207.31451206
Cited by: 0

Abstract

Supplemental Table S3: Surface and intercellular antibodies used for FACS analysis

Fields of Study & Subjects

Breast Cancer Treatment Studies Estrogen and related hormone effects Histone Deacetylase Inhibitors Research

Publication details

Publication date
3 March 2026
Language
EN